[Endometrioid carcinoma of the prostate: a histogenetic dilemma with therapeutic implications]

case-report public-domain-us
View on PubMed

Abstract

An additional case of endometrioid carcinoma of the prostate is presented. We discuss the origin and significance of this controversial and uncommon tumor type. The different histogenic hypotheses that have been put forward not only imply a distinct embryologic conception but also an appropriate therapeutic approach. The good results achieved by antiandrogen therapy in the case reported herein have prompted us to consider this treatment modality as a valid adjunct to surgery.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Prostatic Neoplasms Aged Androgen Antagonists Androgen Antagonists Combined Modality Therapy Cyproterone Cyproterone Cyproterone Cyproterone Acetate Endometriosis Endometriosis Endometriosis Humans Male Prognosis Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-08T06:08:32.324769+00:00
pubmed
last seen: 2026-05-13T22:12:05.481982+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine